Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004. 1998

I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
Faculty of Pharmaceutical Sciences, Chiba University, 1-33, Yayoi-cho, Inage-ku, Chiba 263-8522, Japan.

A new inhibitor of acyl CoA:cholesterol acyltransferase (ACAT), HL-004 [N-(2, 6-diisopropylphenyl)tetradecylthioacetamide], suppressed the synthesis of cholesterol [14C]oleate at 10(-9) approximately 10(-7) M in a concentration-dependent manner in both THP-1 cell-derived macrophages and foam cells prepared from aortic intima of rabbits fed a high cholesterol diet. Incorporation of [3H]cholesterol oleate-beta very low density lipoproteins was not inhibited by HL-004 at 10(-9) approximately 10(-7) M. Release of radioactivity from the cells loaded with [3H]cholesterol oleate-beta very low density lipoproteins was increased by the inhibition of ACAT activity with HL-004. HL-004 did not affect on acid and neutral cholesterol esterases. As a result, cholesterol ester content in foam cells decreased. These data suggested that HL-004 decreases cholesterol ester in foam cells by increasing the release of cholesterol and therefore might suppress atherosclerotic lesions.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002785 Sterol O-Acyltransferase An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26. Acyl-CoA-Cholesterol Acyltransferase,Cholesterol Acyltransferase,Cholesterol Esterifying Enzyme,Acyl CoA Cholesterol Acyltransferase,Acyltransferase, Acyl-CoA-Cholesterol,Acyltransferase, Cholesterol,Enzyme, Cholesterol Esterifying,Esterifying Enzyme, Cholesterol,O-Acyltransferase, Sterol,Sterol O Acyltransferase
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005487 Foam Cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Cell, Foam,Cells, Foam,Foam Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083 Acetanilides Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA. Acetylanilines,N-Phenylacetamides

Related Publications

I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
September 1995, Japanese journal of pharmacology,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
September 1996, Cellular and molecular biology (Noisy-le-Grand, France),
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
November 1998, Japanese journal of pharmacology,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
October 1998, General pharmacology,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
June 1993, Clinica chimica acta; international journal of clinical chemistry,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
January 1998, Life sciences,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
November 2003, The Journal of biological chemistry,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
December 1996, General pharmacology,
I Ishii, and N Yokoyama, and M Yanagimachi, and N Ashikawa, and M Hata, and S Murakami, and Y Asami, and N Morisaki, and Y Saito, and S Ohmori, and M Kitada
September 2002, Planta medica,
Copied contents to your clipboard!